-
International Journal of Women's Health
-
About Dovepress
Open access peer-reviewed scientific and medical journals.
-
Open Access
Dove Medical Press is now a member of the Open Access Initiative
-
An Author's Guide
A guide to help authors get their paper published.
-
Advocacy
Support Open Access and Dove Press
-
Reprints
Promotional Article Monitoring - further details
-
Favored Author Program
Real benefits for authors, including fast-track processing of papers.
Long-term safety, efficacy, and patient acceptability of the intrauterine Copper T-380A contraceptive device
Review
(1992) Views (771) Full article downloads
Authors: Bliss Kaneshiro, Tod Aeby
Published Date July 2010
Volume 2010:2 Pages 211 - 220
DOI: http://dx.doi.org/10.2147/IJWH.S6914
Bliss Kaneshiro, Tod AebyDepartment of Obstetrics and Gynecology, John A Burns School of Medicine, University of Hawaii, Honolulu, Hawaii, USA
Abstract: The intrauterine device (IUD), primarily in the form of the copper IUD, is used by more than 150 million women around the world, making it the most widely used reversible method of contraception. With a remarkably low failure rate of less than 1 per 100 women in the first year of use, the Copper T-380A is in the top tier of contraceptives in terms of efficacy. Risks of utilization include perforation and an increased risk of infection in the first 20 days following insertion. Overall, the number of adverse events is low, making the Copper T-380A a very safe contraceptive method. The most common reasons for the discontinuation of this method are menstrual bleeding and dysmenorrhea. However, cumulative discontinuation rates of Copper T-380A are lower than that have been reported for other methods, indicating that the Copper T-380A is highly acceptable to women. After 5 years, approximately 50% of all women, who have a Copper T-380A inserted, will continue to use this highly effective contraceptive method.
Keywords: contraception, perforation, expulsion, pelvic inflammatory disease, continuation
Readers of this article also read:
Safety, efficacy and patient acceptability of the contraceptive and non-contraceptive uses of the LNG-IUS
Emergency contraception: potential role of ulipristal acetate
Optimal management of nausea and vomiting of pregnancy
Diagnosis and management of pre-eclampsia: an update
Gestational diabetes: risks, management, and treatment options
Future of translational research: Why go pragmatic?
Antibacterial treatment of bacterial vaginosis: current and emerging therapies
Emergency contraception: current options, challenges, and future directions
A case of mitochondrial cardiomyopathy with restrictive transmitral filling pattern
- Interested in being a peer-reviewer?
Click here to register.
- Testimonials
"You do a tremendous job!!" Ruben Restrepo, The University of Texas Health Science Center at San Antonio
- Contraceptive practices in Nigeria: Literature review and recommendation for future policy decisions
- Tinidazole in the treatment of bacterial vaginosis
- Diagnosis and management of pre-eclampsia: an update
- Treating dyspareunia caused by vaginal atrophy: a review of treatment options using vaginal estrogen therapy




